Overview


A multiplex PCR involves detecting multiple targets simultaneously with different primers for each target in a single reaction well. The technique requires two or more probes that can be distinguished from each other and detected simultaneously. An example of multiplex PCR is the simultaneous detection of multiple targets in a single reaction well using different primer pairs for each target. Two or more probes must be distinguishable from each other and detected simultaneously for this technique to work. Different probe technologies are available, all of which use fluorophores. PCR multiplexing is used in life science research, clinical diagnostics, and forensics. PCR detection systems with simultaneous multi-target detection and advances in probe chemistry have made comparative analyses standard in many areas of research and testing.

Multiplex PCR is a widely used molecular biology technique for amplification of multiple targets at once. Using multiple primer pairs in a reaction mixture, multiple target sequences can be amplified. Multiplex PCR allows more than one target sequence to be amplified by including more than one pair of primers. With multiplex PCR, you can save a great deal of time and effort in the laboratory without compromising the utility of the test. During multiplex polymerase chain reaction, several different DNA sequences are amplified at the same time using polymerase chain reaction. In a thermal cycler, multiple primers are used with a temperature-mediated DNA polymerase to amplify DNA in samples. Using multiple primer sets in a single PCR mixture, multiplex-PCR produces amplicons of varying sizes that are specific to different DNA sequences. In a single test run, more information can be gained by targeting multiple sequences at the same time than would be possible with several times the reagents and more time.

Optimum annealing temperatures must be used for each set of primers to work correctly within a single reaction, and amplicon sizes should be different enough to show distinct bands on gel electrophoresis. With multiplex PCR, products are separated by size by gel electrophoresis or capillary electrophoresis, by spatial separation on a surface or bead, or by probe color in real-time PCR.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Multi-PCR Detection Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Multi-PCR Detection Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • F.Hoffman-La Roche Ltd
  • Bio-rad Laboratories
  • Qiagen N.V.
  • Fluidigm Corporation
  • Biomerieux S.A.
  • Agilent Technologgies Inc
  • Takara Bio Inc
  • Qiagen N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Digital PCR
  • Reverse Transcription PCR
  • Conventional PCR
  • Real-Time PCR
  • Hot-Start PCR
  • Multiplex PCR
  • Other

By Application

  • Genetic Sequencing
  • Gene Expression Analysis
  • Nucleic Acid Detection
  • Genotyping
  • Others

By End-Users

  • Hospitals
  • Government Research Institutes
  • Pharmaceuticals Companies
  • Higher Education Institutions

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Multi-PCR Detection Market By Type, By Application, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Multi-PCR Detection Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Multi-PCR Detection Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Multi-PCR Detection Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Multi-PCR Detection Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Digital PCR
        2. Reverse Transcription PCR
        3. Conventional PCR
        4. Real-Time PCR
        5. Hot-Start PCR
        6. Multiplex PCR
        7. Other

  • 8.   Multi-PCR Detection Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Genetic Sequencing
        2. Gene Expression Analysis
        3. Nucleic Acid Detection
        4. Genotyping
        5. Others

  • 9.   Multi-PCR Detection Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Government Research Institutes
        3. Pharmaceuticals Companies
        4. Higher Education Institutions

  • 10.   North America Multi-PCR Detection Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Multi-PCR Detection Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Multi-PCR Detection Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Multi-PCR Detection Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Danaher Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. F.Hoffman-La Roche Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Qiagen N.V.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients